Research ArticleBasic Science Investigations
Preclinical SPECT/CT Imaging of αvβ6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis
Alison E. John, Jeni C. Luckett, Amanda L. Tatler, Ramla O. Awais, Ami Desai, Anthony Habgood, Steve Ludbrook, Andy D. Blanchard, Alan C. Perkins, R. Gisli Jenkins and John F. Marshall
Journal of Nuclear Medicine December 2013, 54 (12) 2146-2152; DOI: https://doi.org/10.2967/jnumed.113.120592
Alison E. John
1Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom
Jeni C. Luckett
2Centre for Biomolecular Sciences, University of Nottingham, Nottingham, United Kingdom
Amanda L. Tatler
1Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom
Ramla O. Awais
3Radiological and Imaging Sciences, University of Nottingham, Nottingham, United Kingdom
Ami Desai
4Institute of Cancer, Queen Mary, University of London, London, United Kingdom; and
Anthony Habgood
1Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom
Steve Ludbrook
5GlaxoSmithKline, Stevenage, United Kingdom
Andy D. Blanchard
5GlaxoSmithKline, Stevenage, United Kingdom
Alan C. Perkins
3Radiological and Imaging Sciences, University of Nottingham, Nottingham, United Kingdom
R. Gisli Jenkins
1Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, United Kingdom
John F. Marshall
4Institute of Cancer, Queen Mary, University of London, London, United Kingdom; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 12
December 1, 2013
Preclinical SPECT/CT Imaging of αvβ6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis
Alison E. John, Jeni C. Luckett, Amanda L. Tatler, Ramla O. Awais, Ami Desai, Anthony Habgood, Steve Ludbrook, Andy D. Blanchard, Alan C. Perkins, R. Gisli Jenkins, John F. Marshall
Journal of Nuclear Medicine Dec 2013, 54 (12) 2146-2152; DOI: 10.2967/jnumed.113.120592
Preclinical SPECT/CT Imaging of αvβ6 Integrins for Molecular Stratification of Idiopathic Pulmonary Fibrosis
Alison E. John, Jeni C. Luckett, Amanda L. Tatler, Ramla O. Awais, Ami Desai, Anthony Habgood, Steve Ludbrook, Andy D. Blanchard, Alan C. Perkins, R. Gisli Jenkins, John F. Marshall
Journal of Nuclear Medicine Dec 2013, 54 (12) 2146-2152; DOI: 10.2967/jnumed.113.120592
Jump to section
Related Articles
Cited By...
- Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies
- Visualisation of interstitial lung disease by molecular imaging of integrin {alpha}v{beta}3 and somatostatin receptor 2
- A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of 18F-FB-A20FMDV2 for Imaging the Integrin {alpha}v{beta}6
- Optimization of a Collagen-Targeted PET Probe for Molecular Imaging of Pulmonary Fibrosis
- Identification of a Novel ITG{alpha}v{beta}6-Binding Peptide Using Protein Separation and Phage Display
- Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models
- In Vivo PET Imaging of the Cancer Integrin {alpha}v{beta}6 Using 68Ga-Labeled Cyclic RGD Nonapeptides
- Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling
- Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin {alpha}v{beta}6 Expression
- {alpha}v{beta}6 integrin may be a potential prognostic biomarker in interstitial lung disease
- Endotyping idiopathic pulmonary fibrosis should improve outcomes for all patients with progressive fibrotic lung disease
- Influenza Promotes Collagen Deposition via {alpha}v{beta}6 Integrin-mediated Transforming Growth Factor {beta} Activation
- Novel approaches to pulmonary fibrosis